| Description |
Potent and selective dual ATP-competitive PI 3-K/mTOR inhibitor (K i values are 1.6, 1.8, 1.9, 2.1 and 16 nM for human PI 3-K δ , α , γ , β , and mTOR, respectively). Displays no significant inhibitory activity at more than 80 protein kinases (concentration ≥ 10 μ M) including hVps34, PI 3-K downstream kinases, and MAPK family members. Orally available. Induces robust cell cycle arrest at the G 1 phase in U87MG cancer cells and antitumor activity in SKOV3 ovarian cancer xenograft models.
|